{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:20:55Z","timestamp":1792099255703,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003971.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000}}],"reference-count":47,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003971.pub4","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T13:49:00Z","timestamp":1486561740000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Methadone for cancer pain"],"prefix":"10.1002","volume":"2017","author":[{"given":"Alexander B","family":"Nicholson","sequence":"first","affiliation":[{"name":"South Tees Hospitals NHS Foundation Trust; Middlesbrough UK TS4 3BW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme R","family":"Watson","sequence":"additional","affiliation":[{"name":"South Tees Hospitals NHS Foundation Trust; Middlesbrough UK TS4 3BW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003971.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cpt196783415","article-title":"A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone","volume":"8","author":"Beaver","year":"1967","journal-title":"Clinical Pharmacololgy and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003971.pub4-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","article-title":"Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study","volume":"22","author":"Bruera","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD003971.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1200\/JCO.1998.16.11.3656","article-title":"Morphine versus methadone in the pain treatment of advanced cancer patients followed up at home","volume":"16","author":"Mercadante","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","article-title":"Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management","volume":"12","author":"Mercadante","year":"2008","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0005|cit5","first-page":"691","article-title":"A comparison of diamorphine with cocaine and methadone (letter)","volume":"4","author":"Twycross","year":"1977","journal-title":"British Journal of Clinical Practice"},{"issue":"4","key":"10.1002\/14651858.CD003971.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0885-3924(86)80042-2","article-title":"A randomized study on oral administration of morphine and methadone in the treatment of cancer pain","volume":"1","author":"Ventafridda","year":"1986","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00520-009-0649-8","article-title":"Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study","volume":"18","author":"Cubero","year":"2010","journal-title":"Supportive Care in Cancer"},{"issue":"1A","key":"10.1002\/14651858.CD003971.pub4-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0002-9343(84)80023-6","article-title":"Combination therapy with ibuprofen and methadone for chronic cancer pain","volume":"77","author":"Ferrer-Brechner","year":"1984","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003971.pub4-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0304-3959(86)90234-4","article-title":"A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer","volume":"25","author":"Gourlay","year":"1986","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3959(89)90233-9","article-title":"Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomised, double blind study","volume":"38","author":"Grochow","year":"1989","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/bjc.2012.593","article-title":"Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone","volume":"108","author":"Lauretti","year":"2013","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/pgmj.40.460.103","article-title":"Double blind trial of dextromoramide, methadone and pethidine in the treatment of severe pain","volume":"40","author":"Matts","year":"1964","journal-title":"Postgraduate Medical Journal"},{"issue":"16","key":"10.1002\/14651858.CD003971.pub4-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.ejca.2011.06.047","article-title":"How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trial","volume":"47","author":"Moksnes","year":"2011","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Morley JS Bridson J Nash TP Miles JB White S Makin MK Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial Palliative Medicine 2003 576 87","DOI":"10.1191\/0269216303pm815oa"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0015|cit15","unstructured":"Prommer E (lead investigator) Methadone versus morphine for cancer related pain clinicaltrials.gov\/ct2\/show\/NCT00573937 (accessed 21 April 2016) 2016"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0016|cit16","unstructured":"Fisch MJ (lead investigator) Methadone, morphine, or oxycodone in treating pain in patients with cancer clinicaltrials.gov\/ct2\/show\/NCT00726830 (accessed 21 April 2016) 2012"},{"issue":"1","key":"10.1002\/14651858.CD003971.pub4-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/papr.12045","article-title":"Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study","volume":"14","author":"Raptis","year":"2014","journal-title":"Pain Practice"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0304-3959(91)90179-2","article-title":"Local toxicity with subcutaneous methadone. Experience of two centers","volume":"45","author":"Bruera","year":"1991","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003971.pub4-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/10966210252785097","article-title":"Methadone use in cancer patients with pain: a review","volume":"5","author":"Bruera","year":"2002","journal-title":"Journal of Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003971.pub4-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpainsymman.2007.11.003","article-title":"Methadone: to ECG or not to ECG.... That is still the question","volume":"36","author":"Cruciani","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s005200000180","article-title":"Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration","volume":"9","author":"Davis","year":"2001","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0022|cit22","unstructured":"Anon More care, less pathway. A review of the Liverpool Care Pathway Report by Baroness Julia Neuberger (Chair), available at www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/212450\/Liverpool_Care_Pathway.pdf"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0304-3959(93)90125-9","article-title":"Methadone in the management of cancer pain: a review","volume":"51","author":"Fainsinger","year":"1993","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD003971.pub4-BIB0024|cit24","first-page":"152","article-title":"The use of methadone in the care of the dying","volume":"4","author":"Gannon","year":"1997","journal-title":"European Journal of Palliative Care"},{"issue":"3","key":"10.1002\/14651858.CD003971.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/15360288.2014.938883","article-title":"Therapeutic challenges in cancer pain management: a systematic review of methadone","volume":"28","author":"Good","year":"2014","journal-title":"Journal of Pain and Palliative Care Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD003971.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","article-title":"The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord","volume":"223","author":"Gorman","year":"1997","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00520-015-3030-0","article-title":"Feelings, perceptions, and expectations of patients during the process of oral cancer diagnosis","volume":"24","author":"Graner","year":"2016","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD003971.pub4-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0030|cit30","first-page":"331","article-title":"Opioid analgesic therapy","volume-title":"Oxford Textbook of Palliative Medicine","author":"Hanks","year":"1998"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0031|cit31","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"15","key":"10.1002\/14651858.CD003971.pub4-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"e3341","DOI":"10.1097\/MD.0000000000003341","article-title":"The adverse events of oxycodone in cancer-related pain: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Ma","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1002\/14651858.CD003971.pub4-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0885-3924(99)00020-2","article-title":"Subcutaneous methadone in terminally ill patients: manageable local toxicity","volume":"18","author":"Mathew","year":"1999","journal-title":"Journal of Pain and Symptom Management"},{"issue":"7","key":"10.1002\/14651858.CD003971.pub4-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0035|cit35","first-page":"299","article-title":"Pathophysiology of pain in cancer and other terminal diseases","volume-title":"Oxford Textbook of Palliative Medicine","author":"Payne","year":"1998"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0036|cit36","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2-3","key":"10.1002\/14651858.CD003971.pub4-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3959(96)03286-1","article-title":"An update on the clinical use of methadone for cancer pain","volume":"70","author":"Ripamonti","year":"1997","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0038|cit38","volume-title":"Palliative Care Formulary","author":"Twycross","year":"1998"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0039|cit39","volume-title":"PCF5 Palliative Care Formulary","author":"Twycross","year":"2014"},{"key":"10.1002\/14651858.CD003971.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.pain.2007.08.022","article-title":"High prevalence of pain in patients with cancer in a large population-based study in The Netherlands","volume":"132","author":"Beuken-van Everdingen","year":"2007","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003971.pub4-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5055\/jom.2013.0167","article-title":"Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain","volume":"9","author":"Beuken-van Everdingen","year":"2013","journal-title":"Journal of Opioid Management"},{"issue":"4","key":"10.1002\/14651858.CD003971.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1","article-title":"A validation study of the WHO method for cancer pain relief","volume":"59","author":"Ventafridda","year":"1987","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003971.pub4-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","article-title":"Actual and potential drug interactions associated with methadone","volume":"9","author":"Weschules","year":"2008","journal-title":"Pain Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003971.pub4-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011056.pub2","article-title":"Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain","author":"Wiffen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD003971.pub4-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003971","article-title":"Methadone for cancer pain","author":"Nicholson","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003971.pub4-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003971.pub2","article-title":"Methadone for cancer pain","author":"Nicholson","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003971.pub4-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003971.pub3","article-title":"Methadone for cancer pain","author":"Nicholson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003971.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:11:03Z","timestamp":1709035863000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003971.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003971.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]}}}